138 related articles for article (PubMed ID: 8890723)
1. Immunoglobulins from Graves' disease patients stimulate phospholipase A2 and C systems in FRTL-5 and human thyroid cells.
Atwa MA; Smallridge RC; Burch HB; Gist ID; Lu R; Abo-Hashem EM; el-Kannishy MH; Burman KD
Eur J Endocrinol; 1996 Sep; 135(3):322-7. PubMed ID: 8890723
[TBL] [Abstract][Full Text] [Related]
2. Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor.
Di Cerbo A; Di Paola R; Menzaghi C; De Filippis V; Tahara K; Corda D; Kohn LD
J Clin Endocrinol Metab; 1999 Sep; 84(9):3283-92. PubMed ID: 10487700
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulins from Graves' patients stimulate phospholipase-A2 in FRTL5 thyroid cells.
Di Cerbo A; Di Girolamo M; Guardabasso V; De Filippis V; Corda D
J Clin Endocrinol Metab; 1992 Mar; 74(3):585-92. PubMed ID: 1310998
[TBL] [Abstract][Full Text] [Related]
4. Phospholipase C activation by Na+/Ca2+ exchange is essential for monensin-induced Ca2+ influx and arachidonic acid release in FRTL-5 thyroid cells.
Wang XD; Kiang JG; Scheibel LW; Smallridge RC
J Investig Med; 1999 Sep; 47(8):388-96. PubMed ID: 10510591
[TBL] [Abstract][Full Text] [Related]
5. Untreated Graves' but not remission Graves' immunoglobulin G preparations increase intracellular Ca2+ in FRTL-5 thyroid cells.
Kuwabara A; Okajima F; Akiyama H; Kobayashi I; Kondo Y
Endocr J; 1996 Oct; 43(5):457-67. PubMed ID: 8980884
[TBL] [Abstract][Full Text] [Related]
6. P2-purinergic stimulation of iodide efflux in FRTL-5 rat thyroid cells involves parallel activation of PLC and PLA2.
Smallridge RC; Gist ID
Am J Physiol; 1994 Aug; 267(2 Pt 1):E323-30. PubMed ID: 8074212
[TBL] [Abstract][Full Text] [Related]
7. A phospholipase C inhibitor, U-73122, blocks TSH-induced inositol trisphosphate production, Ca2+ increase and arachidonic acid release in FRTL-5 thyroid cells.
Wang XD; Kiang JG; Smallridge RC
Biochim Biophys Acta; 1994 Aug; 1223(1):101-6. PubMed ID: 8061042
[TBL] [Abstract][Full Text] [Related]
8. Graves' immunoglobulin G stimulates iodothyronine 5'-deiodinating activity in FRTL-5 rat thyroid cells.
Toyoda N; Nishikawa M; Horimoto M; Yoshikawa N; Mori Y; Yoshimura M; Masaki H; Tanaka K; Inada M
J Clin Endocrinol Metab; 1990 Jun; 70(6):1506-11. PubMed ID: 1971826
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-dependent thyroid cell proliferation induced by immunoglobulins from patients with Graves' disease.
Di Paola R; Menzaghi C; De Filippis V; Corda D; Di Cerbo A
J Clin Endocrinol Metab; 1997 Feb; 82(2):670-3. PubMed ID: 9024274
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous signal pathways through TSH receptors in porcine thyroid cells following stimulation with Graves' immunoglobulin G.
Szabó J; Fóris G; Keresztes T; Csabina S; Varga Z; Bakó G; Mezõsi E; Nagy E; Paragh G; Leövey A
Eur J Endocrinol; 1998 Sep; 139(3):355-8. PubMed ID: 9758449
[TBL] [Abstract][Full Text] [Related]
11. [The effects of TSH, cholera toxin and Graves' IgG on cAMP production in cultured human thyroid adenoma cells in monolayer].
Tsuboi K
Nihon Naibunpi Gakkai Zasshi; 1985 May; 61(5):541-53. PubMed ID: 2862066
[TBL] [Abstract][Full Text] [Related]
12. Evidence for the involvement of protein kinase C isoforms in alpha-1 adrenergic activation of phospholipase A2 in FRTL-5 thyroid cells.
Wang XD; Kiang JG; Atwa MA; Smallridge RC
J Investig Med; 1996 Dec; 44(9):566-74. PubMed ID: 9035611
[TBL] [Abstract][Full Text] [Related]
13. An investigation of the ability of TSH and Graves' immunoglobulin G to increase intracellular calcium in human thyroid cells, rat FRTL-5 thyroid cells and eukaryotic cells transfected with the human TSH receptor.
MacNeil S; Munro DS; Metcalfe R; Cotterell S; Ruban L; Davies R; Weetman AP
J Endocrinol; 1994 Dec; 143(3):527-40. PubMed ID: 7836899
[TBL] [Abstract][Full Text] [Related]
14. Receptor cross-talk can optimize assays for autoantibodies to the thyrotropin receptor: effect of phenylisopropyladenosine on adenosine 3',5'-monophosphate and inositol phosphate levels in rat FRTL-5 thyroid cells.
Hidaka A; Okajima F; Ban T; Kosugi S; Kondo Y; Kohn LD
J Clin Endocrinol Metab; 1993 Nov; 77(5):1164-9. PubMed ID: 8077307
[TBL] [Abstract][Full Text] [Related]
15. Subgroups of Graves' patients identified on the basis of the biochemical activities of their immunoglobulins.
Di Cerbo A; Di Paola R; Bonati M; Zingrillo M; De Filippis V; Corda D
J Clin Endocrinol Metab; 1995 Sep; 80(9):2785-90. PubMed ID: 7673424
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
[TBL] [Abstract][Full Text] [Related]
17. Permissive stimulation of Ca(2+)-induced phospholipase A2 by an adenosine receptor agonist in a pertussis toxin-sensitive manner in FRTL-5 thyroid cells: a new 'cross-talk' mechanism in Ca2+ signalling.
Shimegi S; Okajima F; Kondo Y
Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):845-51. PubMed ID: 8192675
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay.
Vitti P; Rotella CM; Valente WA; Cohen J; Aloj SM; Laccetti P; Ambesi-Impiombato FS; Grollman EF; Pinchera A; Toccafondi R; Kohn LD
J Clin Endocrinol Metab; 1983 Oct; 57(4):782-91. PubMed ID: 6136523
[TBL] [Abstract][Full Text] [Related]
19. Independent coupling of the human tachykinin NK2 receptor to phospholipases C and A2 in transfected Chinese hamster ovary cells.
Catalioto RM; Cucchi P; Renzetti AR; Criscuoli M; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):395-403. PubMed ID: 9826060
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of cyclic AMP and iodide accumulation responses to thyroid-stimulating immunoglobulins in cultured FRTL-5 cells.
Bidey SP; Ekins RP
Clin Endocrinol (Oxf); 1986 Apr; 24(4):447-58. PubMed ID: 2874907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
